Login to Your Account



Basic science to POC: startup Bionetix takes translational approach

By Cornelia Zou
Staff Writer

Thursday, October 19, 2017

HONG KONG – Established in February, South Korean biotech startup Bionetix Inc. has already secured a partnership with Southern Research to develop cancer drugs, and plans to move into the clinic with a lead program targeting glaucoma in 2019.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription